UEA I Lectin (FITC)
GTX01512
ApplicationsImmunoFluorescence, ImmunoCytoChemistry
Product group Proteins / Signaling Molecules
Overview
- SupplierGeneTex
- Product NameUEA I Lectin (FITC)
- Delivery Days Customer9
- ApplicationsImmunoFluorescence, ImmunoCytoChemistry
- CertificationResearch Use Only
- Concentration1 mg/ml
- ConjugateFITC
- Scientific DescriptionThe anti-H (O) hemagglutinating activity of Ulex europaeus has been used widely to confirm blood group O activity. UEA I binds to many glycoproteins and glycolipids containing alpha -linked fucose residue. The purified lectin appears to be a dimer of two distinct polypeptide chains associated by noncovalent forces. This lectin does not react with Lea active blood group substance. The native protein has pI=6.0-6.1 and exhibits a Molecular weight 60,000-68,000 during gel filtration on Sephadex column. This lectin will hemagglutinate fresh blood group O cells at 2-5microg/ml.Inhibiting/Eluting sugars: 50-100 mM L-fucoseCarbohydrate-Binding Specificity of UEA I: L-Fualpha1,2Galbeta1,4GlcNAcbeta1,6R
- Storage Instruction2°C to 8°C
- UNSPSC12352202
References
- Si-Wu Water Extracts Protect against Colonic Mucus Barrier Damage by Regulating Muc2 Mucin Expression in Mice Fed a High-Fat Diet. Ruan Z et al., 2022 Aug 18, FoodsRead more
- Small proline-rich protein 2A is a gut bactericidal protein deployed during helminth infection. Hu Z et al., 2021 Nov 5, ScienceRead more
- Ultrasonic microbubble VEGF gene delivery improves angiogenesis of senescent endothelial progenitor cells. Lee YN et al., 2021 Jun 29, Sci RepRead more
- Retinal Glial and Choroidal Vascular Pathology in Donors Clinically Diagnosed With Stargardt Disease. Edwards MM et al., 2020 Jul 1, Invest Ophthalmol Vis SciRead more
- A role for mast cells in geographic atrophy. Ogura S et al., 2020 Aug, FASEB JRead more
- Choriocapillaris dropout in early age-related macular degeneration. Lutty GA et al., 2020 Mar, Exp Eye ResRead more
- Mast Cell-Derived Tryptase in Geographic Atrophy. McLeod DS et al., 2017 Nov 1, Invest Ophthalmol Vis SciRead more